Page results
-
The Clinical and Research Informatics Unit at UCLH consists of a team of clinicians, researchers, software developers, business intelligence analysts and data scientists working together to develop a robust environment for the analysis of clinical data.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
-
Dr Katherine Clesham is a consultant haematologist specialising in the treatment of teenagers and young adults with acute leukaemia and patients undergoing stem cell transplantation and CAR-T therapy.
-
The High Court has today (26 March) ruled that parents can consent on behalf of their child for hormone-blocking treatment in cases of gender dysphoria.
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
The spasticity team at The National Hospital for Neurology and Neurosurgery (NHNN) has produced a series of short animated videos. The films were funded by The National Brain Appeal, the charity dedicated to supporting NHNN.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
File results
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023
-
FOI2017223 Patients not eligible for NHS care
-
FOI2017224 Expenditure on validation of RTT codes
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis